Advertisement
Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Health-System Pharmacy, Vol. 63, Issue 21, 2135-2143
Copyright © 2006 by American Society of Health-System Pharmacists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Driscoll, D. F.
Right arrow Articles by Nehne, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Driscoll, D. F.
Right arrow Articles by Nehne, J.

Practice Reports

Establishing a stability window for medium- and long-chain-triglyceride lipid-based total nutrient admixtures using USP standards

David F. Driscoll, Mansi Parikh, Anthony P. Silvestri, Karsten Klütsch, Bruce R. Bistrian and Jörg Nehne

DAVID F. DRISCOLL, PH.D., is Senior Researcher, Nutrition/Infection Laboratory, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, and Assistant Professor of Medicine, Harvard Medical School (HMS), Boston. MANSI PARIKH, M.S., is Associate Research Scientist, Pharmaceutical Research and Development, Johnson and Johnson, Spring House, PA. ANTHONY P. SILVESTRI, B.S., is Clinical Pharmacist, Sterile Compounding Unit, BIDMC. KARSTEN KLUTSCH, PH.D., is Manager, Hospital Care, Strategic Marketing for IV Therapeutics, B. Braun, Melsungen, Germany. BRUCE R. BISTRIAN, M.D., PH.D., is Chief, Nutrition/Infection Laboratory, BIDMC, and Professor of Medicine, HMS. JORG NEHNE, PH.D., is Director, Hospital Care, Pilot Plant Pharma, B. Braun.

Address correspondence to Dr. Driscoll at the Department of Medicine, Beth Israel Deaconess Medical Center, Baker 605, 185 Pilgrim Road, Boston, MA 02215 (ddriscol{at}bidmc.harvard.edu).


Purpose. The stability window of medium-chain triglyceride (MCT) and long-chain-triglyceride (LCT) lipid-based total nutrient admixtures (TNAs) was studied.

Methods. Sixteen different admixtures were selected for study. Of these, eight base macronutrient concentrations representing low and high concentrations were selected, along with low and high concentrations of electrolytes. All TNAs studied contained 2 mg of elemental iron as part of the trace-element formulation, an amount previously shown to produce unstable TNAs with pure LCT-based lipid injectable emulsions. All admixtures were prepared in triplicate and analyzed over five time intervals: time 1 (immediately after preparation), time 2 (after four days of storage at 6 ± 2 °C), and times 3, 4, and 5, corresponding to 6, 24, and 30 hours of storage at 25 ± 2 °C, respectively, after time 2. Stability was measured by comparing results with USP standards for fat globule size in lipid injectable emulsions.

Results. A total of 48 admixtures were studied. Samples at each time interval showed an inconsistent but general increase in the number of globules with a diameter of >1.8 µ m over time. All admixtures met both the proposed pharmacopeial criteria for stability with respect to mean droplet size and volume-weighted proportion of fat globules with a diameter of >5 µ m.

Conclusion. A wide range of macronutrients and micronutrients were tested in a series of MCT–LCT-based TNAs and found to be stable. The use of MCTs and LCTs in lipid injectable emulsions confers greater stability to TNAs than has been achieved with pure LCT-based formulations.

Index terms: Additives; Concentration; Drops; Electrolytes; Fat emulsions; Formulations; Iron; Minerals; Nutrition; Size; Stability; Standards; Storage; Temperature; Triglycerides; United States Pharmacopeia

 



This article has been cited by other articles:


Home page
Nutr Clin PractHome page
G. Hardy and M. Puzovic
Formulation, Stability, and Administration of Parenteral Nutrition With New Lipid Emulsions
Nutr Clin Pract, October 1, 2009; 24(5): 616 - 625.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
D. F. Driscoll, P.-R. Ling, C. Andersson, and B. R. Bistrian
Hepatic Indicators of Oxidative Stress and Tissue Damage Accompanied by Systemic Inflammation in Rats Following a 24-Hour Infusion of an Unstable Lipid Emulsion Admixture
JPEN J Parenter Enteral Nutr, May 1, 2009; 33(3): 327 - 335.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
D. F. Driscoll, A. Thoma, R. Franke, K. Klutsch, J. Nehne, and B. R. Bistrian
Lipid globule size in total nutrient admixtures prepared in three-chamber plastic bags
Am. J. Health Syst. Pharm., April 1, 2009; 66(7): 649 - 656.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
D. F. Driscoll
Safety and Stability of Lipid Emulsions--Response
Nutr Clin Pract, June 1, 2007; 22(3): 370 - 372.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society of Health-System Pharmacists.
Advertisement